PerkinElmer Q4 Revenues Up 10 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that its revenues climbed almost 10 percent in the fourth quarter.

For the three months ended Jan. 2, the firm said revenues totaled $470 million, compared to $428.5 million for the year-ago period. It exceeded consensus Wall Street estimates of $461.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.